EHG — Econ Healthcare (Asia) Cashflow Statement
0.000.00%
Last trade - 00:00- SG$51.59m
- SG$64.76m
- SG$43.51m
- 72
- 78
- 76
- 92
Annual cashflow statement for Econ Healthcare (Asia), fiscal year end - March 31st, SGD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.3 | 3.88 | 6.83 | 0.861 | 5.63 |
| Depreciation | |||||
| Non-Cash Items | 1.74 | 1.94 | 0.941 | 4.36 | 1.93 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.123 | -1.36 | 1.55 | -0.052 | -5.18 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 11.7 | 10.6 | 15.6 | 12.6 | 11.7 |
| Capital Expenditures | -2.14 | -1.89 | -2.44 | -2.63 | -3.63 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -5.87 | -0.991 | -0.116 | -1.88 | 1.47 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8 | -2.88 | -2.56 | -4.51 | -2.16 |
| Financing Cash Flow Items | -1.02 | -3.17 | -0.69 | -1.4 | -1.29 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.14 | -8.11 | -4.35 | 1.98 | -11.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.49 | -0.417 | 8.73 | 10 | -1.48 |